Patna(Imam Ali/Insaaf Times) Indian company Bharat Biotech said that the COVID nasal drug ‘Incovac (BBV 154)’ for the covid epidemic will be available at the market and government level from the fourth week of January next year.The company has said that it will be available through the Covin portal.
All adults receiving the covid vaccine and covid shield will be able to receive it as a third or booster dose. Private hospitals will get this medicine at Rs 800 per dose and the government will get Rs 325 per dose.In a statement issued in Hyderabad on Monday, the company said that Incovac has also received approval as the first two doses for protection against Covid.
Bharat Biotech said that Incovac has received approval from the Central Drug Standard Control Organization (CDSCO). This medicine will be given to the patient through the nose. This drug is specially designed for citizens of low and middle-income citizens.